Anesiva, Inc. was incorporated on January 19, 1999 in Delaware. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for pain management. Their portfolio of products includes:
Zingo and Adlea are different drugs, each with its own mechanisms of action. Zingo is comprised of microcrystals of lidocaine delivered into the skin by compressed gas. Zingo employs a proprietary needle-free dispenser. Adlea is a novel non-opioid drug candidate that is a vanilloid receptor 1 agonist, or TRPV1 agonist, based on the compound capsaicin which provides analgesia for between two and three months.